DB18867InvestigationalProtein Based Therapies
Zinlirvimab is under investigation in clinical trial NCT03707977 (Dual Bnab Treatment in Children).
- Mechanism
- Curator reviewed
Pharmacologically active on Envelope glycoprotein gp160
- Also known as
- Anti-hiv-1 human monoclonal antibody targeting v3 glycan supersite on the hiv-1 envelope protein (10-1074)
- Code names
- 10-1074 · 10-1074-LS · GS-2872 · GS-5423
Resolves to
Compound
Targets
What you can answer from here — as of July 27, 2026
Which drugs share a target with Zinlirvimab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account